Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

420 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identifying prognostic factors in Japanese women with pseudomyxoma peritonei: a retrospective clinico-pathological study of the Tohoku Gynecologic Cancer Unit.
Kojimahara T, Nakahara K, Shoji T, Sugiyama T, Takano T, Yaegashi N, Yokoyama Y, Mizunuma H, Tase R, Satou H, Tanaka T, Motoyama T, Kurachi H. Kojimahara T, et al. Among authors: motoyama t. Tohoku J Exp Med. 2011 Feb;223(2):91-6. doi: 10.1620/tjem.223.91. Tohoku J Exp Med. 2011. PMID: 21263209 Free article.
Characteristic features of ovarian borderline tumors with invasive implant.
Ohta T, Ohmichi M, Hayasaka T, Saitoh M, Kojimahara T, Kawagoe J, Nakahara K, Motoyama T, Kurachi H. Ohta T, et al. Among authors: motoyama t. Arch Gynecol Obstet. 2005 Oct;272(4):278-82. doi: 10.1007/s00404-005-0002-5. Epub 2005 Oct 13. Arch Gynecol Obstet. 2005. PMID: 16012777
Endometrioid adenocarcinoma with a functioning stroma.
Hayasaka T, Nakahara K, Kojimahara T, Saito-Sekiguchi M, Motoyama T, Kurachi H. Hayasaka T, et al. Among authors: motoyama t. J Obstet Gynaecol Res. 2007 Jun;33(3):381-3. doi: 10.1111/j.1447-0756.2007.00541.x. J Obstet Gynaecol Res. 2007. PMID: 17578372
Inhibition of inhibitor of nuclear factor-kappaB phosphorylation increases the efficacy of paclitaxel in in vitro and in vivo ovarian cancer models.
Mabuchi S, Ohmichi M, Nishio Y, Hayasaka T, Kimura A, Ohta T, Kawagoe J, Takahashi K, Yada-Hashimoto N, Seino-Noda H, Sakata M, Motoyama T, Kurachi H, Testa JR, Tasaka K, Murata Y. Mabuchi S, et al. Among authors: motoyama t. Clin Cancer Res. 2004 Nov 15;10(22):7645-54. doi: 10.1158/1078-0432.CCR-04-0958. Clin Cancer Res. 2004. PMID: 15569997
420 results